Corrigendum: Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma

Affiliations

¹ Department of Pathology, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, China.
² Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
³ Department of Oncology, The Affiliated Huai'an Hospital of Xuzhou Medical University and the Second People's Hospital of Huai'an, Huai'an, China.
⁴ Department of Thoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
⁵ Department of Geriatrics, The Affiliated Huai'an Hospital of Xuzhou Medical University and the Second People's Hospital of Huai'an, Huai'an, China.

^# Contributed equally.

Published Erratum

Yang Ding et al. Front Immunol. 2025.

. 2025 Apr 30:16:1613095.

doi: 10.3389/fimmu.2025.1613095. eCollection 2025.

¹ Department of Pathology, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, China.
² Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
³ Department of Oncology, The Affiliated Huai'an Hospital of Xuzhou Medical University and the Second People's Hospital of Huai'an, Huai'an, China.
⁴ Department of Thoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
⁵ Department of Geriatrics, The Affiliated Huai'an Hospital of Xuzhou Medical University and the Second People's Hospital of Huai'an, Huai'an, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1575084.].

Keywords: lung adenocarcinoma; machine learning; non-small cell lung cancer; prognosis signature; single-cell RNA sequencing.

Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma.
Ding Y, Wang D, Yan D, Fan J, Ding Z, Xue L. Ding Y, et al. Front Immunol. 2025 Apr 16;16:1575084. doi: 10.3389/fimmu.2025.1575084. eCollection 2025. Front Immunol. 2025. PMID: 40308576 Free PMC article.